Merck Sharp Dohme B V
USPTO Trademark & Patent Filings
Trademark applications and grants for Merck Sharp Dohme B V. Merck Sharp Dohme B V has 112 trademark applications. The latest application filed is for "FERTI-STUDIO"
- Company Aliases
- MERCK SHARP & DOHME B.V.
- Merck Sharp & Dohme B.V. - BN Haarlem NL
- Merck Sharp & Dohme B.V. - Rahway NJ US
- MERCK SHARP & DOHME B.V. - Haarlem NL
- Merck Sharp & Dohme B.V. - Haarlem NL
Trademarks Patents
| Patent Application | Date |
|---|---|
| BELANTAMAB MAFODOTIN IN COMBINATION WITH PEMBROLIZUMAB FOR TREATING CANCER 20220096650 - 17/426723 OPALINSKA; Joanna | 2022-03-31 |
| ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 20210403560 - 17/469359 Carven; Gregory John ; et al. | 2021-12-30 |
| KIT FOR AND METHOD OF ASSEMBLING AN APPLICATOR FOR INSERTING AN IMPLANT 20210268249 - 17/326373 BEELEN; Dennis Cornelis Franciscus ; et al. | 2021-09-02 |
| 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS 20210230166 - 17/142202 Barf; Tjeerd A. ; et al. | 2021-07-29 |
| COMBINATION THERAPIES FOR TREATING CANCER 20200289493 - 16/612363 Bobilev; Dmitri ; et al. | 2020-09-17 |
| NCAGE Code | H2255 | MERCK SHARP & DOHME B.V. |
| CAGE Code | H2255 | MERCK SHARP & DOHME B.V. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 